Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Response Inhibition”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00262275
What this trial is testing

Optimum Platelet Inhibition After Coronary Bypass Surgery

Who this might be right for
Ischemic Heart Disease
Papworth Hospital NHS Foundation Trust
Testing effectiveness (Phase 2)Ended earlyNCT01730495
What this trial is testing

Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome

Who this might be right for
Chronic Fatigue SyndromeMyalgic Encephalomyelitis
Haukeland University Hospital 4
Not applicableStudy completedNCT01060930
What this trial is testing

Diesel Exhaust Inhalation, Systemic Nitric Oxide Inhibition and Cardiac Output

Who this might be right for
Vascular Function in Healthy Volunteers
University of Edinburgh 14
Early research (Phase 1)Study completedNCT03723395
What this trial is testing

A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib

Who this might be right for
Drug-drug Interaction
Seagen Inc. 116
Not applicableUnknownNCT05715567
What this trial is testing

Re-EValuating the Inhibition of Stress Erosions (REVISE) - COVID-19 Cohort Study

Who this might be right for
COVID-19GastroIntestinal Bleeding
McMaster University 600
Testing effectiveness (Phase 2)Study completedNCT04247165
What this trial is testing

Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.

Who this might be right for
Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer
Herlev Hospital 55
Large-scale testing (Phase 3)Study completedNCT00557193
What this trial is testing

Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Undifferentiated LeukemiaChildhood T Acute Lymphoblastic Leukemia
Children's Oncology Group 218
Testing effectiveness (Phase 2)WithdrawnNCT04471714
What this trial is testing

Effects of Baclofen on Presynaptic Inhibition in Humans

Who this might be right for
Spasticity, MuscleSpinal Cord Injuries
University of Alberta
Not applicableStudy completedNCT00039819
What this trial is testing

Nerve Stimulation to Modify a Spinal Reflex

Who this might be right for
Healthy
National Institute of Neurological Disorders and Stroke (NINDS) 25
Testing effectiveness (Phase 2)Study completedNCT00119457
What this trial is testing

Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)

Who this might be right for
Venous ThromboembolismEmbolism and ThrombosisHip Fractures
vTv Therapeutics 300
Not applicableStudy completedNCT01081600
What this trial is testing

89Zr-trastuzumab PET for Imaging the Effect of HSP90 Inhibition

Who this might be right for
Breast Cancer
University Medical Center Groningen 7
Early research (Phase 1)Ended earlyNCT01940809
What this trial is testing

Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
BRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Melanoma+5 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT03926117
What this trial is testing

Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition

Who this might be right for
Chronic Kidney DiseasesInflammation
Novo Nordisk A/S 264
Not applicableEnded earlyNCT01006018
What this trial is testing

DPP-4 Inhibition and TZD for DM Prevention

Who this might be right for
Prediabetic State
Emory University 3
Post-approval studies (Phase 4)Study completedNCT00405717
What this trial is testing

Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel

Who this might be right for
Ischemic Heart DiseaseAcute Coronary Syndromes
Shenyang Northern Hospital 1,300
Testing effectiveness (Phase 2)Study completedNCT04470050
What this trial is testing

Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal

Who this might be right for
Opioid Withdrawal
BioXcel Therapeutics Inc 225
Testing effectiveness (Phase 2)Study completedNCT01991197
What this trial is testing

Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.

Who this might be right for
PsoriasisType 2 Diabetes Mellitus
University College Dublin 20
Post-approval studies (Phase 4)Study completedNCT01557140
What this trial is testing

Trial of Carvedilol in Chronic Chagas Cardiomyopathy

Who this might be right for
Chagas CardiomyopathyHeart FailureDilated Cardiomyopathy
Federal University of Minas Gerais 42
Post-approval studies (Phase 4)Study completedNCT02129725
What this trial is testing

Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle.

Who this might be right for
Metabolic Syndrome
Vanderbilt University Medical Center 15
Post-approval studies (Phase 4)Study completedNCT02942550
What this trial is testing

Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients

Who this might be right for
STEMIMorphineTicagrelor+1 more
Karolinska University Hospital 82
Next Page